top of page
Wegovy’s $499 ‘Price Cut’: The Hype, The Reality, and The Part Everyone’s Ignoring
Novo Nordisk just announced Wegovy for $499/month on its direct-to-consumer platform—but is this price cut really a game-changer?
Mar 112 min read
Medicare Coverage for Weight Loss Medications Could Cost $35 Billion by 2034, Says CBO
New Proposal to Expand Medicare Coverage Raises Questions on Cost and Potential Savings
Nov 19, 20242 min read
FTC Sues Prescription Drug Middlemen for Inflating Insulin Prices—What Does that Mean?
Caremark, Express Scripts, and OptumRx Face Allegations of Rigging the Rebate System
Nov 19, 20244 min read
The US Senate Grills Novo Nordisk on High Prices for Ozempic and Wegovy
A Heated Exchange on the Super Star Weight Loss Drugs' Price, Big Pharma and PBM's Finger-Pointing Game
Sep 26, 20244 min read
Employers Struggle with Weight Loss Drug Coverage as ACA Plan Availability Varies by State
Balancing Soaring Costs and Employee Well-being.
May 17, 20244 min read
Benefit Boost: Federal Employees Now Enjoy Expanded Coverage for GLP-1 Weight Loss Drugs such as Wegovy
New FEHB Mandate Enhance GLP-1 Coverage for Federal Employees.
May 17, 20244 min read
Medicaid and Weight Loss Drugs: Navigating Coverage in a Fragmented Landscape
How Do State Medicaid Programs Differ in Weight Loss Drug Coverage?
May 17, 20243 min read
Medicare's New Stance on Weight Loss Drugs: A Path to Broader Coverage
Wegovy and Other Drugs Now More Accessible Under Revised Medicare Rules
May 17, 20243 min read
What is Pharmacy Benefit Managers (PBM)?
A Closer Look at the Controversial Pillars of Prescription Drug Costs.
Feb 16, 20243 min read
Shortages of Weight Loss Drugs Open Doors for Compounding Pharmacies Amid Concerns
Addressing Weight Loss Drug Shortages with Caution and Care.
Feb 11, 20243 min read
Breaking Down the Costs of Ozempic, Wegovy, Mounjaro and Zepbound
A Closer Look at Cost Structure of Ozempic and Other New Weight Loss Drugs.
Feb 9, 20244 min read
How do you get these drugs—Ozempic, Wegovy, Mounjaro & Zepbound?
It is the No.1 question people are asking. Let's take a look.
Feb 6, 20243 min read
bottom of page